310 related articles for article (PubMed ID: 19364832)
21. Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data.
Sun J; Gunzer F; Westendorf AM; Buer J; Scharfe M; Jarek M; Gössling F; Blöcker H; Zeng AP
J Biotechnol; 2005 May; 117(2):147-61. PubMed ID: 15823404
[TBL] [Abstract][Full Text] [Related]
22. Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli.
Mohsin M; Guenther S; Schierack P; Tedin K; Wieler LH
Int J Med Microbiol; 2015 Jan; 305(1):20-6. PubMed ID: 25465158
[TBL] [Abstract][Full Text] [Related]
23. Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice.
Myhal ML; Laux DC; Cohen PS
Eur J Clin Microbiol; 1982 Jun; 1(3):186-92. PubMed ID: 6756909
[TBL] [Abstract][Full Text] [Related]
24. Respiration of Escherichia coli in the mouse intestine.
Jones SA; Chowdhury FZ; Fabich AJ; Anderson A; Schreiner DM; House AL; Autieri SM; Leatham MP; Lins JJ; Jorgensen M; Cohen PS; Conway T
Infect Immun; 2007 Oct; 75(10):4891-9. PubMed ID: 17698572
[TBL] [Abstract][Full Text] [Related]
25. An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine.
Møller AK; Leatham MP; Conway T; Nuijten PJ; de Haan LA; Krogfelt KA; Cohen PS
Infect Immun; 2003 Apr; 71(4):2142-52. PubMed ID: 12654836
[TBL] [Abstract][Full Text] [Related]
26. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.
Wadolkowski EA; Burris JA; O'Brien AD
Infect Immun; 1990 Aug; 58(8):2438-45. PubMed ID: 2196227
[TBL] [Abstract][Full Text] [Related]
27. Glycogen and maltose utilization by Escherichia coli O157:H7 in the mouse intestine.
Jones SA; Jorgensen M; Chowdhury FZ; Rodgers R; Hartline J; Leatham MP; Struve C; Krogfelt KA; Cohen PS; Conway T
Infect Immun; 2008 Jun; 76(6):2531-40. PubMed ID: 18347038
[TBL] [Abstract][Full Text] [Related]
28. Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources.
Leatham MP; Stevenson SJ; Gauger EJ; Krogfelt KA; Lins JJ; Haddock TL; Autieri SM; Conway T; Cohen PS
Infect Immun; 2005 Dec; 73(12):8039-49. PubMed ID: 16299298
[TBL] [Abstract][Full Text] [Related]
29. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
Yoshimura K; Matsui T; Itoh K
Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
[TBL] [Abstract][Full Text] [Related]
30. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
31. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice.
Gagnon M; Kheadr EE; Dabour N; Richard D; Fliss I
Int J Food Microbiol; 2006 Aug; 111(1):26-33. PubMed ID: 16822570
[TBL] [Abstract][Full Text] [Related]
32. Escherichia coli F-18 phase locked 'on' for expression of type 1 fimbriae is a poor colonizer of the streptomycin-treated mouse large intestine.
McCormick BA; Klemm P; Krogfelt KA; Burghoff RL; Pallesen L; Laux DC; Cohen PS
Microb Pathog; 1993 Jan; 14(1):33-43. PubMed ID: 8100608
[TBL] [Abstract][Full Text] [Related]
33. Variable efficacy of a vaccine and direct-fed microbial for controlling Escherichia coli O157:H7 in feces and on hides of feedlot cattle.
Stanford K; Hannon S; Booker CW; Jim GK
Foodborne Pathog Dis; 2014 May; 11(5):379-87. PubMed ID: 24673729
[TBL] [Abstract][Full Text] [Related]
34. Survival of Escherichia coli O157:H7 in feces from corn- and barley-fed steers.
Bach SJ; Stanford K; McAllister TA
FEMS Microbiol Lett; 2005 Nov; 252(1):25-33. PubMed ID: 16299922
[TBL] [Abstract][Full Text] [Related]
35. Fate of enterohemorrhagic Escherichia coli O157:H7 in bovine feces.
Wang G; Zhao T; Doyle MP
Appl Environ Microbiol; 1996 Jul; 62(7):2567-70. PubMed ID: 8779595
[TBL] [Abstract][Full Text] [Related]
36. Chemostat modeling of Escherichia coli persistence in conventionalized mono-associated and streptomycin-treated mice.
Rang C; Midtvedt T; Molin S; Chao L
Can J Microbiol; 2001 Jan; 47(1):86-90. PubMed ID: 15049455
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli.
Reissbrodt R; Hammes WP; dal Bello F; Prager R; Fruth A; Hantke K; Rakin A; Starcic-Erjavec M; Williams PH
FEMS Microbiol Lett; 2009 Jan; 290(1):62-9. PubMed ID: 19016876
[TBL] [Abstract][Full Text] [Related]
38. Ethanolamine Influences Human Commensal Escherichia coli Growth, Gene Expression, and Competition with Enterohemorrhagic E. coli O157:H7.
Rowley CA; Anderson CJ; Kendall MM
mBio; 2018 Oct; 9(5):. PubMed ID: 30279284
[TBL] [Abstract][Full Text] [Related]
39. Screening of the novel colicinogenic gram-negative rods against pathogenic Escherichia coli O157:H7.
Mushtaq H; Bakht J; Bacha N
Indian J Med Microbiol; 2015 Feb; 33 Suppl():67-72. PubMed ID: 25657160
[TBL] [Abstract][Full Text] [Related]
40. Genotype and phenotypes of an intestine-adapted Escherichia coli K-12 mutant selected by animal passage for superior colonization.
Fabich AJ; Leatham MP; Grissom JE; Wiley G; Lai H; Najar F; Roe BA; Cohen PS; Conway T
Infect Immun; 2011 Jun; 79(6):2430-9. PubMed ID: 21422176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
